Biotech Checkpoint Therapeutics Submits Biologics License Application to FDA for Cosibelimab as a Treatment for Patients with Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma January 4, 2023
Biotech Cidara Therapeutics Nominates First Oncology Clinical Development Candidate from its Cloudbreak® Platform January 4, 2023
Biotech Galmed reports results from the Open-Label part of the ARMOR study showing improvements in histology, imaging, and biomarkers with Aramchol January 4, 2023
Biotech Immutep Achieves 50% Enrollment Milestone in Randomised Phase IIb TACTI-003 Trial for First Line Head & Neck Cancer January 4, 2023
Biotech New Executive Leadership Team Appointed to Accelerate XOMA’s Differentiated Royalty Monetization Strategy January 4, 2023
Biotech Aravive Announces Complete Enrollment in the Global Registrational Phase 3 AXLerate-OC Trial for Platinum-Resistant Ovarian Cancer January 4, 2023
Biotech Genprex Announces Selection of Preclinical Data for Oral Presentation at 16th International Conference on Advanced Technologies & Treatments for Diabetes January 4, 2023
Biotech EyePoint Pharmaceuticals Promotes Jay S. Duker, M.D. to President and Chief Operating Officer January 4, 2023
Search
biopharmaceutical
January 4, 2023
January 4, 2023
January 4, 2023
January 4, 2023
January 4, 2023
January 4, 2023
January 4, 2023
January 4, 2023
January 4, 2023
January 4, 2023
